Author

Seyedeh Sahar Mortazavi Farsani

University of MinnesotaORCID 0000-0002-8705-1569Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anuradha PanditiD· 1 shared Brittney ThieleiD· 1 shared Charles M. RudiniD· 1 shared Li WangiD· 1 shared Luke H. HoeppneriD· 1 shared Marie Christine Aubry· 1 shared Parvathy ManojiD· 1 shared Sk. Kayum AlamiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anuradha PanditORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression

Sk. Kayum Alam, Anuradha Pandit, Li Wang, Seyedeh Sahar Mortazavi Farsani, Brittney Thiele, Parvathy Manoj, Marie Christine Aubry, Vivek Verma, Charles M. Rudin, Ying‐Chun Lo, Luke H. Hoeppner

This study shows that dopamine D2 receptor agonists reduce angiogenesis and inhibit chemotherapy-refractory small cell lung cancer progression by targeting tumour-associated endothelial cells.

Cell Death and Disease · May 9, 2025Peer-reviewedCancer Biology